CRO Services

A clinical trial run across two geographies usually means three vendors, two standards, and no single owner — and every handoff between adviser, CRO, and local agent taxes the timeline and dilutes accountability. That is the offshore CRO friction tax. The way to avoid it is an in-house CRO India model with a DCGI-registered operation,

Choosing an oncology CRO in India is not about who is cheapest — it is about whose data will survive an FDA inspection. The CROs worth shortlisting share four traits: access to premier, high-volume cancer centers; in-house regulatory expertise across the FDA and India’s DCGI; a documentation standard built for U.S./EU inspection from day one;

Last quarter, a top-20 pharma company pulled biostatistics, data management, and pharmacovigilance out of a $400 million full-service CRO model. Kept the CRO for site management and recruitment infrastructure. Hired an FSP provider for everything else. The CRO’s stock dropped 3% on the earnings call when the CEO mentioned ‘evolving client preferences.’ That’s Wall Street

The CRO You Hired in 2023 Isn’t the CRO You Need in 2026 — How the Outsourcing Model Is Breaking Your CRO contract was designed for a trial that no longer exists operationally. The market fundamentals shifted, the regulatory environment changed, and the competitive dynamics reversed. But your contract language and CRO selection criteria haven’t